Unknown

Dataset Information

0

A collagen-based scaffold delivering exogenous microrna-29B to modulate extracellular matrix remodeling.


ABSTRACT: Directing appropriate extracellular matrix remodeling is a key aim of regenerative medicine strategies. Thus, antifibrotic interfering RNA (RNAi) therapy with exogenous microRNA (miR)-29B was proposed as a method to modulate extracellular matrix remodeling following cutaneous injury. It was hypothesized that delivery of miR-29B from a collagen scaffold will efficiently modulate the extracellular matrix remodeling response and reduce maladaptive remodeling such as aggressive deposition of collagen type I after injury. The release of RNA from the scaffold was assessed and its ability to silence collagen type I and collagen type III expression was evaluated in vitro. When primary fibroblasts were cultured with scaffolds doped with miR-29B, reduced levels of collagen type I and collagen type III mRNA expression were observed for up to 2 weeks of culture. When the scaffolds were applied to full thickness wounds in vivo, reduced wound contraction, improved collagen type III/I ratios and a significantly higher matrix metalloproteinase (MMP)-8: tissue inhibitor of metalloproteinase (TIMP)-1 ratio were detected when the scaffolds were functionalized with miR-29B. Furthermore, these effects were significantly influenced by the dose of miR-29B in the collagen scaffold (0.5 versus 5 ?g). This study shows a potential of combining exogenous miRs with collagen scaffolds to improve extracellular matrix remodeling following injury.

SUBMITTER: Monaghan M 

PROVIDER: S-EPMC3983959 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A collagen-based scaffold delivering exogenous microrna-29B to modulate extracellular matrix remodeling.

Monaghan Michael M   Browne Shane S   Schenke-Layland Katja K   Pandit Abhay A  

Molecular therapy : the journal of the American Society of Gene Therapy 20140109 4


Directing appropriate extracellular matrix remodeling is a key aim of regenerative medicine strategies. Thus, antifibrotic interfering RNA (RNAi) therapy with exogenous microRNA (miR)-29B was proposed as a method to modulate extracellular matrix remodeling following cutaneous injury. It was hypothesized that delivery of miR-29B from a collagen scaffold will efficiently modulate the extracellular matrix remodeling response and reduce maladaptive remodeling such as aggressive deposition of collage  ...[more]

Similar Datasets

| S-EPMC6034485 | biostudies-literature
| S-EPMC7907089 | biostudies-literature
| S-EPMC5067961 | biostudies-literature
| S-EPMC7957025 | biostudies-literature
| S-EPMC3757098 | biostudies-literature
| S-EPMC4443916 | biostudies-literature
| S-EPMC7072441 | biostudies-literature
| S-EPMC5610346 | biostudies-literature
| S-EPMC3569720 | biostudies-literature
| S-EPMC7531623 | biostudies-literature